Johanna Wassermann
Sorbonne Université(FR)Assistance Publique – Hôpitaux de Paris(FR)Pitié-Salpêtrière Hospital(FR)
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, Hepatocellular Carcinoma Treatment and Prognosis
Most-Cited Works
- → Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib(2014)152 cited
- → Redifferentiation of radioiodine-refractory thyroid cancers(2020)89 cited
- → Association of body mass index and cardiotoxicity related to anthracyclines and trastuzumab in early breast cancer: French CANTO cohort study(2019)73 cited
- → Cardiac arrhythmia considerations of hormone cancer therapies(2019)71 cited
- → Outcomes and Prognostic Factors in Radioiodine Refractory Differentiated Thyroid Carcinomas(2015)63 cited
- → Benefit of adjuvant trastuzumab-based chemotherapy in T1ab node-negative HER2-overexpressing breast carcinomas: a multicenter retrospective series(2012)50 cited